Quick Summary
Pygeum (Prunus africana) is a medicinal plant traditionally used in African communities for various health conditions including benign prostatic hyperplasia (BPH), prostate cancer, wounds, diabetes, and malaria. It contains bioactive phytochemicals such as tannins, saponins, alkaloids, flavonoids, terpenoids, phytosterols, and fatty acids. Traditional and preclinical evidence suggests multiple pharmacological effects including anti-inflammatory, antimicrobial, antiandrogenic, antioxidant, and astringent properties. However, human clinical evidence remains limited and inconclusive, particularly for BPH.
What is it?
Pygeum is derived from the bark of Prunus africana, a tree native to Africa. It has been used for centuries in traditional African medicine. Extracts of Pygeum bark are used in various herbal supplements, often aimed at supporting prostate health and other uses.
Traditional Uses
- Benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)
- Prostate cancer management (traditional/ethnomedicinal use)
- Wound healing
- Management of diabetes and malaria
- Anti-inflammatory and antimicrobial applications
Active Compounds
Pygeum contains a range of bioactive phytochemicals, including:
- Tannins
- Saponins
- Alkaloids
- Flavonoids
- Terpenoids
- Phytosterols
- Fatty acids
Potential Benefits with Evidence Levels
Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS)
Evidence level: Insufficient and inconclusive clinical evidence.
Systematic reviews and clinical trials focusing on phytotherapies including Pygeum suggest only modest benefits for LUTS related to BPH. Some studies report improvement in symptoms and urinary flow rates compared to placebo, but these trials often have methodological limitations. High-quality, placebo-controlled randomized trials specifically on Pygeum are lacking.
Hair Loss in Menopausal Women
Evidence level: Preliminary, pilot clinical evidence.
Limited open-label pilot studies of botanical supplements (not isolated Pygeum) suggest potential improvement in hair density and reduction of hair shedding in females experiencing telogen effluvium. Larger, placebo-controlled randomized clinical trials are necessary to confirm these findings.
Prostate Cancer
Evidence level: Preclinical evidence (in vitro and ethnomedicinal).
Pygeum is used traditionally for prostate cancer alongside other African medicinal plants. In vitro studies have shown cytotoxic activity against prostate cancer cell lines. However, no clinical trial data in humans have been identified to substantiate its efficacy.
Anti-inflammatory and Antimicrobial Effects
Evidence level: Preclinical and ethnopharmacological evidence.
Extracts of Pygeum contain compounds that demonstrate anti-inflammatory, antimicrobial, and antioxidant activities in laboratory and ethnobotanical studies.
Side Effects
Adverse effects of Pygeum are not clearly documented in clinical studies, and safety data remain limited. Further clinical research is needed to better characterize its safety profile.
Drug Interactions
No specific drug interactions have been documented in current data. Caution is advised when using Pygeum concurrently with other medications until further pharmacokinetic and interaction studies are available.
Who Should Avoid It
Due to the lack of sufficient clinical data, Pygeum should be used cautiously in populations with insufficient safety information. It is not recommended during pregnancy and breastfeeding unless prescribed by a qualified healthcare provider.
Evidence Limitations
- Most clinical evidence is limited by small sample sizes, lack of placebo controls, and methodological weaknesses.
- High-quality randomized controlled trials focusing specifically on Pygeum alone are lacking.
- Many reports are ethnopharmacological or preclinical; human clinical data are insufficient.
- Standardization of extract formulations and dosages varies, limiting result comparability.
- Safety, adverse effects, and drug interactions are poorly documented in human studies.
References
- Ndung’u JK et al. (2024). A Comprehensive Review of Ethnomedicinal Uses, Phytochemistry, Pharmacology, and Toxicity of Prunus africana (Hook. F.) Kalkman from Africa. Scientifica. doi:10.1155/2024/8862996
- Huang Z et al. (2025). Botanical drug preparations for alleviating hair loss in menopausal women: a global ethnopharmacological mini-review. Front Pharmacol. doi:10.3389/fphar.2025.1725691
- Bwesigye T et al. (2026). In vitro cytotoxicity of medicinal plants used in prostate cancer management in Africa: a systematic review. Trop Med Health. doi:10.1186/s41182-026-00923-9
- Antoniou V et al. (2023). Role of Phytotherapy in the Management of BPH: A Summary of the Literature. J Clin Med. doi:10.3390/jcm12051899
- Csikós E et al. (2021). Treatment of Benign Prostatic Hyperplasia by Natural Drugs. Molecules. doi:10.3390/molecules26237141
- Dedhia RC, McVary KT. (2008). Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. doi:10.1016/j.juro.2008.01.094
- Kudamba A et al. (2023). Medicinal plants used in the management of cancers by residents in the Elgon Sub-Region, Uganda. BMC Complement Med Ther. doi:10.1186/s12906-023-04273-5
- Bodeker G et al. (2014). Prunus africana (Hook.f.) Kalkman: the overexploitation of a medicinal plant species and its legal context. Altern Ther Health Med. doi:10.1089/acm.2013.0459
Last Reviewed
April 2024
Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. The effects of herbs can vary and may interact with medications or medical conditions. Always consult a qualified healthcare professional before starting any herbal treatment or supplement.